Zurich's $10.8 Billion Beazley Acquisition Clears Australian Regulatory Hurdle

Zurich Insurance Group's landmark bid to acquire UK-based Lloyd's specialty insurer Beazley plc has cleared an important regulatory checkpoint. On June 17, 2026, the Australian Competition and Consumer Commission (ACCC) announced that the £8.1 billion (US$10.8 billion) acquisition 'may be put into effect,' concluding that the combination is unlikely to substantially lessen competition in any market.

The all-cash deal, announced on March 2, 2026, would establish what the two companies describe as the world's leading specialty insurance underwriter, with approximately US$15 billion in pro forma gross written premiums. The combined business would be headquartered in London and leverage Beazley's established Lloyd's of London platform, positioning the merged entity as a top-ten participant in the US Excess and Surplus Lines market and a leader at Lloyd's. Beazley's strong cyber insurance franchise — including its Full Spectrum Cyber offering with in-house incident response — is considered central to the strategic rationale.

Under the agreed terms, Beazley shareholders will receive 1,335 pence per share, comprising 1,310 pence in cash plus a permitted dividend of 25 pence — a premium of approximately 62.8% to Beazley's closing price on January 16, 2026. Beazley shareholders overwhelmingly approved the deal in April 2026, with 99.9% of votes cast in support. The acquisition followed a months-long pursuit in which Beazley initially rebuffed several Zurich approaches before accepting a sweetened offer.

Zurich still needs approvals from the UK's Prudential Regulation Authority and Financial Conduct Authority, Lloyd's of London, the Swiss Financial Market Supervisory Authority (FINMA), and the European Union's competition watchdog, which received Zurich's merger filing on June 10. The transaction is being implemented through a court-sanctioned scheme of arrangement, with completion anticipated in the second half of 2026. Zurich CEO Mario Greco has said the deal accelerates the company's specialty strategy, and analysts expect it to be earnings-accretive by 2027 with double-digit returns on investment by 2029. The deal is among the largest specialty-focused insurance acquisitions of the past decade.